Literature DB >> 12543000

Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease.

Benjamin M Segal1.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is widely depicted as the prototypical CD4+ Th1-mediated autoimmune disease. Microglia and perivascular macrophages are believed to act as antigen-presenting cells during the effector phase of EAE. In this article, recent data that challenge these conceptions are reviewed. Several recent studies have shown that myelin-reactive CD8+ T cells can mediate inflammatory demyelination. Furthermore, dendritic-like cells have been detected in EAE lesions and implicated in encephalitogenic T-cell activation. Although Th1 polarizing monokines, such as interleukin-12 (IL-12) and possibly IL-23, are critical for the manifestation of EAE, individual Th1 effector cytokines were found to be dispensible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543000     DOI: 10.1007/s11882-003-0017-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  70 in total

1.  Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis.

Authors:  V Kumar; J Maglione; J Thatte; B Pederson; E Sercarz; E S Ward
Journal:  Int Immunol       Date:  2001-06       Impact factor: 4.823

Review 2.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

Authors:  P V Lehmann; E E Sercarz; T Forsthuber; C M Dayan; G Gammon
Journal:  Immunol Today       Date:  1993-05

Review 3.  Regulation of IL-12 receptor expression in early T-helper responses implies two phases of Th1 differentiation: capacitance and development.

Authors:  K M Murphy; T L Murphy; S J Szabo; N G Jacobson; M L Guler; J D Gorham; U Gubler
Journal:  Chem Immunol       Date:  1997

4.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta.

Authors:  S Issazadeh; J C Lorentzen; M I Mustafa; B Höjeberg; A Müssener; T Olsson
Journal:  J Neuroimmunol       Date:  1996-09       Impact factor: 3.478

6.  Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains.

Authors:  T T Duong; F D Finkelman; B Singh; G H Strejan
Journal:  J Neuroimmunol       Date:  1994-08       Impact factor: 3.478

7.  Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker.

Authors:  M K Waldor; S Sriram; R Hardy; L A Herzenberg; L A Herzenberg; L Lanier; M Lim; L Steinman
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

8.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.

Authors:  L B Nicholson; J M Greer; R A Sobel; M B Lees; V K Kuchroo
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

9.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

10.  Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes.

Authors:  D S Linthicum; J A Frelinger
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  24 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

2.  Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.

Authors:  Juhua Zhou; Prakash Nagarkatti; Yin Zhong; Mitzi Nagarkatti
Journal:  J Neuroimmunol       Date:  2010-06       Impact factor: 3.478

3.  Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.

Authors:  Junda Kel; Judith Oldenampsen; Mariken Luca; Jan Wouter Drijfhout; Frits Koning; Lex Nagelkerken
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

5.  T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.

Authors:  Heather M Grifka-Walk; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2016-05-24       Impact factor: 3.478

6.  CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.

Authors:  Yaping Yan; Xiaoli Ding; Ke Li; Bogoljub Ciric; Shuai Wu; Hui Xu; Bruno Gran; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

7.  Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.

Authors:  Elisabeth R Mari; Jason N Moore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Clin Exp Neuroimmunol       Date:  2015-03-22

8.  Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.

Authors:  Sarah A Imam; Mary K Guyton; Azizul Haque; Arthur Vandenbark; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

9.  IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.

Authors:  Heather M Grifka-Walk; David A Giles; Benjamin M Segal
Journal:  Eur J Immunol       Date:  2015-08-14       Impact factor: 5.532

10.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.